MedPath

Study of the Efficacy and Tolerance of Light Therapy in Sensitive Skin

Not Applicable
Completed
Conditions
Sensitive Skin
Interventions
Device: LED light
Registration Number
NCT03279003
Lead Sponsor
University Hospital, Brest
Brief Summary

Light-emitting diode (LED) light therapy is increasingly used successfully and without adverse effects in diabetic leg ulcer, chronic low back pain, chronic myofacial pain in the neck and in several dermatoses such as acne, Psoriasis, alopecia areata and skin rejuvenation. A Korean study conducted in 2013 suggested its effectiveness in patients with sensitive skin in connection with rosacea, acne, eczema. The objective of the study is to perform a study in subjects with a sensitive skin without associated dermatosis.

Detailed Description

The objective of the study is to evaluate the efficacy of light-emitting diode therapy in subjects with sensitive skin and to assess pain improvement, evaluation of improvement in pruritus and evaluation of treatment tolerance.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Age greater than or equal to 18 years
  • Age less than or equal to 70
  • Sensitive skin defined by a score ≥ 40 on the Sensiscale scale
  • Patient able to consent
Exclusion Criteria
  • Persons under 18 years of age or over.
  • Persons suffering from disorders of higher functions preventing comprehension of the questionnaire.
  • Pregnancy.
  • Analgesic or medication acting on the nervous system.
  • Other dermatosis of the face (example: rosacea, seborrheic dermatitis, acne ...).
  • Neurological or psychiatric illness.
  • A photosensitizing drug.
  • Refusal of patient
  • Patients under legal protection

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Light-emitting diode therapyLED lightExposure to LED light
Primary Outcome Measures
NameTimeMethod
Efficacy of light therapy2 months

The improvement of sensitive skin symptoms will be measured by the Sensiscale scale

Secondary Outcome Measures
NameTimeMethod
Assessment of pain improvement2 months

Pain improvement will be done by self-evaluation of the patients, using a visual analog scale

Assessment of the tolerance2 months

At the end of the study, patients will be questioned about the possible occurrence of side effects listed in the patient's notebook during the 8 weeks of treatment.

Assessment of improvement in pruritus2 months

The improvement of pruritus will be done by self-evaluation of the patients, using a visual analog scale

Trial Locations

Locations (1)

CHRU de Brest

🇫🇷

Brest, France

© Copyright 2025. All Rights Reserved by MedPath